This Discussion Forum is a communication tool for those involved in clinical trials of Investigational Medicinal Products (IMP), to converse about clinical trials legislation and GCP requirements. The Forum provides an ideal opportunity for extended communication between clinical research/development professionals allowing AGCP users to put forward their questions, comments, and feedback of ways in which they can manage robust quality procedures that ensure compliance and which dovetail with their own business needs and resources. This forum should not be used for reporting serious breaches, safety events or making formal complaints. These should follow the regular routes that are already in place by the relevant country regulatory authority. Please read the Forum Introduction and Rules before posting on this forum.

Homepage Forums